Try our Advanced Search for more refined results
Stamoulis & Weinblatt
-
Answer | Filed: May 07, 2024 | Entered: May 07, 2024 Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Answer to Counterclaim
ANSWER to 243 Answer to Complaint, Counterclaim by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
-
Answer | Filed: May 07, 2024 | Entered: May 07, 2024 Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Answer to Counterclaim
ANSWER to 242 Answer to Complaint, Counterclaim by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
-
Answer | Filed: May 07, 2024 | Entered: May 07, 2024 Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Answer to Counterclaim
ANSWER to 244 Answer to Complaint, Counterclaim by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login